Itraconazole versus steroids in post operative cases of allergic fungal rhinosinusitis: a randomized controlled trial

Authors

  • Ankit Aggarwal Civil Hospital, Khanna, Punjab, India
  • Khushboo Goel Department of Otorhinolaryngology and Head and Neck Surgery, Government Medical College, Patiala, Punjab, India
  • Sanjeev Bhagat Department of Otorhinolaryngology and Head and Neck Surgery, Government Medical College, Patiala, Punjab, India
  • Dimple Sahni Department of Otorhinolaryngology and Head and Neck Surgery, Government Medical College, Patiala, Punjab, India
  • Dinesh Kumar Sharma Department of Otorhinolaryngology and Head and Neck Surgery, Government Medical College, Patiala, Punjab, India
  • Vishav Yadav Department of Otorhinolaryngology and Head and Neck Surgery, Government Medical College, Patiala, Punjab, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20233591

Keywords:

AFRS, Itraconazole, Antifungal, Steroid, FESS

Abstract

This study was aimed to compare the effect of oral steroids and itraconazole in reducing the recurrence in allergic fungal rhinosinusitis (AFRS) patients undergoing ESS. In this randomized controlled trial, 50 patients of both sexes aged between 15-60 years with AFRS were subjected to functional endoscopic sinus surgery (ESS). In the post-operative period, patients were randomly divided into 2 groups containing 25 patients each. Group A received systemic steroid followed by topical steroid. Group B received oral itraconazole. Patients were followed at the end of 6, 10 and 14 weeks after surgery. Sinonasal outcome test 22 (SNOT-22) Lund Kennedy endoscopic score (LKES), AEC and serum total IgE were repeated at each post-operative visit and compared with the preoperative values. Repeat NCCT nose and PNS was done at 14th week to look for recurrence. Statistically significant difference was seen between the two groups in AEC, LKES and SNOT-22 with group A showing more significant improvement than group B, but not in serum IgE and Lund Mackay computed tomography (LMCT) score. The group A had 24% (n=6) recurrence rate, while group B had 44% (n=11) recurrence rate. The difference in the two groups in recurrence was not statistically significant. We evaluated multiple parameters including radiological and endoscopic scores to find the difference between the two drugs and found steroid to be superior than itraconazole.

References

Safirstein BH. Allergic bronchopulmonary aspergillosis with obstruction of the upper respiratory tract. Chest. 1976;70(6):788-90.

Kuhn FA, Javer AR. Allergic fungal rhinosinusitis: our experience. Arch Otolaryngol Head Neck Surg. 1998;124(10):1179-80.

Robert S, Grant B. Functional Endoscopic Sinus Surgery. Am Fam Physician. 1998;58(3):707-18.

Ferguson BJ. What role do systemic corticosteroids, immunotherapy, and antifungal drugs play in the therapy of allergic fungal rhinosinusitis? Arch Otolaryngol Head Neck Surg. 1998;124(10):1174-8.

Rudmik L, Hoy M, Schlosser RJ, Harvey RJ, Welch KC, Lund V et al. Topical therapies in the management of chronic rhinosinusitis: an evidence‐based review with recommendations. Int Forum Aller Rhinol. 2013;3(4):281-98.

Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Aller Clin Immunol. 2003;111(5):952-7.

Bent III JP, Kuhn FA. Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope. 1996;106(11):1331-4.

Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest. 1991;100(3):813-9.

Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Eng J Med. 2000;342(11):756-62.

Granville L, Minnie C, Patricia C, Ostrowski M, Truong LD. Fungal sinusitis: histological spectrum and correlation with culture. J Laryngol Otol. 2004;118(11):914.

Nikakhlagh S, Khodadai A, Kanani M, Saki N. The effect of the oral itraconazole on the management of allergic fungal sinusitis. Biomed Pharmacol J. 2015;8:85-9.

Ryan MW, Clark CM. Allergic fungal rhinosinusitis and the unified airway: the role of antifungal therapy in AFRS. Curr Aller Asthma Rep. 2015;15(12):1-6.

Khalil Y, Tharwat A, Abdou AG, Essa E, Essawy AH, Elnakib O et al. The role of antifungal therapy in the prevention of recurrent allergic fungal rhinosinusitis after functional endoscopic sinus surgery: a randomized, controlled study. Ear Nose Throat J. 2011;90(8):E1-7.

Rojita M, Samal S, Pradhan P, Venkatachalam VP. Comparison of steroid and itraconazole for prevention of recurrence in allergic fungal rhinosinusitis: a randomized controlled trial. J Clin Diagnostic Res. 2017;11(4):MC01.77

Reda R, Wageh W, Fawaz M, Mikhaiel W. Comparison between local steroids and local steroids plus itraconazole effect in prevention of recurrence of allergic fungal sinusitis in hypertensive and/or diabetic patients. Egyp J Otolaryngol. 2019;35(1):25-9.

Dhote KS, Dhoke PR, Harkare VV, Deosthale NV, Khadakkar SP. Post-operative management of Allergic fungal sinusitis (ASF): role of Itraconazole. J Evolution Med Dental Sci. 2014;3(32):8729-35.

Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(3):S1-32.

Roshan KV, Sourabha KP, Abhilash AF, Naresh KP, Arunaloke C, Paramjeet S. Role of preoperative versus postoperative itraconazole in allergic fungal rhinosinusitis. Medical Mycol. 2016;55(6):1-10.

Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;50:1-298.

Lund VJ, Kennedy DW. Quantification for staging sinusitis. Anna Otol Rhinol Laryngol. 1995;104(10):17-21.

Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology. 1993;31:183-90.

Marple BF, Mabry RL. Allergic fungal sinusitis: learning from our failures. Am J Rhinol. 2000;14(4):223-6.

Downloads

Published

2023-11-27

Issue

Vol. 9 No. 12 (2023): December 2023

Section

Case Reports